<p>Harvard carries clout, not just on a resume but in matters of actual importance–and the school is going to do something good with it. </p> <p> </p> <p>Along with Yale, University of Pennsylvania, Brown, and Boston University–the latter three of which Bloomberg News did not deem worthy of including in the headline of its article today–Harvard is releasing a set of provisions that will dictate how drugs developed on campus will be marketed. </p> <p> </p> <p>Read more after the jump.</p>
<p>The quick and dirty about what's been going on around the Ancient Eight (and some other schools too).</p><p>A Yale sophomore died last Sunday. Andre Narcisse '12—an Exeter graduate and aspiring Economics concentrator of Haitian descent—dreamed of someday becoming a Wall Street executive. Yale police officials do not suspect foul play. Yale College Dean Mary Miller told the Yale Daily News that it would be premature and inappropriate to speculate, but added she is hoping to address concerns about alcohol and drug use on campus.</p><p>A freshman at Princeton is suing the university during midterm season, after her request to receive extended time on exams because of her learning disabilities was denied. She argued that poor midterm exam grades freshman fall would cause her “irreparable harm.” FlyBy sympathizes but thinks she should chill out.</p><p>More after the jump.
The study came on the heels of China’s establishment of the C9, an Ivy League-like group of nine universities in China intended to raise the profile of Chinese education. But while the rankings bore good news for Harvard, none of the ARWU’s top 200 schools was in China.